Roche
Tracked across 9 events · 95 articles · First seen Apr 22, 2025 · Last active May 28, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Regulatory
Impact: Roche announced a $50 billion investment in the United States to expand its manufacturing, R&D, and distribution capabilities, aiming to mitigate the impact of potential tariffs and boost its U.S. presence. This move is expected to increase its export of medicines from the U.S.
Apr 22, 2025 · 6 articles
Business
PatentVest, a division of MDB Capital Holdings, released a comprehensive report titled 'The Triple-Agonist Race: Retatrutide, Twenty-Seven Programs, and the Hidden Patent War Behind the Next Obesity Market' on May 8, 2026. The report analyzes…
Impact: Roche is mentioned as a significant player in the competitive landscape of obesity drug development.
May 08, 2026 · 6 articles
Accidents
A confirmed Ebola Virus Disease outbreak has been reported in Democratic Republic of the Congo — Ituri Province, Democratic Republic of the Congo, with 246 suspected cases and 65 deaths. Preliminary laboratory results from France…
Impact: Roche is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.
May 15, 2026 · 6 articles
Business
Impact: Roche, Justin Tucker's representative, expressed disappointment with the National Football League's decision but advised Justin Tucker to accept the resolution.
Jun 26, 2025 · 12 articles
Domestic
Impact: Roche, among other pharmaceutical companies, had previously announced investments in U.S. production due to the threat of tariffs, but the new, higher tariffs introduce further uncertainty.
Sep 26, 2025 · 7 articles
Business
Zealand Pharma has announced the initiation of a DKK 1.3 billion (USD 200 million) share buy-back program, effective from May 7, 2026, to October 31, 2026. The program, managed by Danske Bank, aims to meet…
Impact: Zealand Pharma expects to receive USD 700 million in milestone payments from Roche in 2026, contributing to Zealand Pharma's strong financial position.
May 07, 2026 · 6 articles
International
Impact: Roche's vice chair, André Hoffmann, is a co-chair of the World Economic Forum annual meeting.
Jan 19, 2026 · 6 articles
Business
Kiran Mazumdar-Shaw, the founder and chairperson of Biocon, has formally announced her niece, Claire Mazumdar, as her future successor. This move is part of Biocon's long-term leadership and succession planning strategy, aiming for a gradual…
Impact: Claire Mazumdar helped forge a major partnership with Roche during her time at PLOS Medicine.
May 05, 2026 · 40 articles
80
Zealand Pharma expects milestone payments RocheZealand Pharma Initiates...
NEWSDESK
Track Roche live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard